The drug-device combination developed by MIT spinout Lumicell is poised to reduce repeat surgeries and ensure more complete tumor removal.

The combination of phototherapy and chemotherapy could offer a more effective way to fight aggressive tumors.

Novel method to scale phenotypic drug screening drastically reduces the number of input samples, costs, and labor required to execute a screen.

Study reveals the drug, 5-fluorouracil, acts differently in different types of cancer — a finding that could help researchers design better drug combinations.

MIT scientists’ discovery yields a potent immune response, could be used to develop a potential tumor vaccine.

Fasting helps intestinal stem cells regenerate and heal injuries but also leads to a higher risk of cancer in mice, MIT researchers report.

The model could help clinicians assess breast cancer stage and ultimately help in reducing overtreatment.

A chip the size of a pack of cards uses fewer resources and a smaller footprint than existing automated manufacturing platforms and could lead to more affordable cell therapy manufacturing.

By capturing short-lived RNA molecules, scientists can map relationships between genes and the regulatory elements that control them.

An atlas of human protein kinases enables scientists to map cell signaling pathways with unprecedented speed and detail.